AMD
Clinical trials for AMD explained in plain language.
Never miss a new study
Get alerted when new AMD trials appear
Sign up with your email to follow new studies for AMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy could end frequent eye injections for wet AMD
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment aims to help the eye produce its own medicine to stop leaky blood vessels, potentially replacing the need for repeated eye injecti…
Matched conditions: AMD
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
300 patients tracked after eye disease treatments – what really happens?
Knowledge-focused OngoingThis study follows 300 patients with chronic eye conditions like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy who recently received treatment. Researchers will measure changes in eye pressure, vision, and other outcomes over time. The goal is to unde…
Matched conditions: AMD
Sponsor: Interstat LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC